Skip to main content
Springer Nature Link
Log in
Menu
Find a journal Publish with us Track your research
Search
Cart
  1. Home
  2. Chinese Science Bulletin
  3. Article

BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis

  • Article
  • Oncology
  • Open access
  • Published: 20 July 2011
  • Volume 56, pages 2444–2449, (2011)
  • Cite this article
Download PDF

You have full access to this open access article

Chinese Science Bulletin
BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis
Download PDF
  • LingYi Dong1,
  • KeWei Jiang1,
  • YanBin Zhang1,
  • Hui Zhang1,
  • HongQing Zhuo1,
  • ZhiRong Cui1,
  • YingJiang Ye1 &
  • …
  • Shan Wang1 
  • 790 Accesses

  • 7 Citations

  • Explore all metrics

Abstract

We previously showed that B cell receptor associated protein 31(BAP31) was significantly upregulated in colorectal cancer compared with normal mucosa epithelia. However, its expression pattern and pathological role in colorectal cancer are not clearly understood. In this study, we investigated whether the expression of BAP31 was associated with the clinicopathological parameters of colorectal cancer. The expression pattern of BAP31 was detected by immunohistochemistry on a tissue microarray in both primary tumor and paired distant normal mucosa samples from 120 consecutive colorectal cancer patients. Furthermore, BAP31 protein expression was also determined in twenty colorectal adenomas and eight liver metastasis samples. There was positive expression of BAP31 in 64.17% of primary tumors and 6.67% in distant normal mucosa (P=0.000). Negative expression of BAP31 was correlated with distant metastasis (P=0.036) and lower tumor differentiation grade (P=0.001). Patients with BAP31-negative expression showed significantly lower overall survival rate (P=0.003) compared to patients with BAP31-positive expression. Our results demonstrate that BAP31 may serve as a candidate prognostic marker in colorectal cancer and negative BAP31 expression may lead to more aggressive invasion of colorectal cancer.

Article PDF

Download to read the full article text

Similar content being viewed by others

Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma

Article 26 November 2015

Targeting BAP1 with small compound inhibitor for colon cancer treatment

Article Open access 08 February 2023

Biological roles of the B cell receptor-associated protein 31: Functional Implication in Cancer

Article 13 January 2021

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.
  • Cancers
  • Colon cancer
  • Colorectal cancer
  • Gastrointestinal cancer
  • Rectal cancer
  • Tumour-suppressor Proteins
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistic 2008. CA Cancer J Clin, 2008, 58}: 71–

    Article  Google Scholar 

  2. Winawer S J. Colorectal cancer screening. Best Pract Res Clin Gastroenterol, 2007, 21: 1031–1048

    Article  Google Scholar 

  3. Jema A, Siegel R, Ward E, et al. Cancer statistics 2009. CA Cancer J Clin, 2009, 59: 225–249

    Article  Google Scholar 

  4. Wolpin B, Meyerhardt J, Mamon H, et al. Adjuvant treatment of colorectal cancer. CA Cancer J Clin, 2007, 57: 168–185

    Article  Google Scholar 

  5. Zhang Y, Ye Y, Shen D, et al. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci, 2010, 101: 523–529

    Article  Google Scholar 

  6. Kim K M, Adachi T, Nielsen P J, et al. Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J, 1994, 13: 3793–3800

    Google Scholar 

  7. Annaert W G, Becker B, Kistner U, et al. Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J Cell Biol, 1997, 139: 1397–1410

    Article  Google Scholar 

  8. Breckenridge D G, Stojanovic M, Marcellus R C, et al. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol, 2003, 160: 1115–1127

    Article  Google Scholar 

  9. Chandra D, Choy G, Deng X, et al. Association of active caspase 8 with the mitochondrial membrane during apoptosis: Potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cel Biol, 2004, 24: 6592–6607

    Article  Google Scholar 

  10. Nguyen M, Breckenridge D G, Ducret A, et al. Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol Cel Biol, 2000, 20: 6731–6740

    Article  Google Scholar 

  11. Madeo F, Durchschlag M, Kepp O, et al. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals. Cell Cycle, 2009, 8: 639–642

    Article  Google Scholar 

  12. Delom F, Emadali A, Cocolakis E, et al. Calnexin-dependent regulation of tunicamycininduced apoptosis in breast carcinoma MCF-7 cells. Cell Death Differ, 2007, 14: 586–596

    Article  Google Scholar 

  13. Panaretakis T, Kepp O, Brockmeier U, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J, 2009, 28: 578–590

    Article  Google Scholar 

  14. Watson A J. Apoptosis and colorectal cancer. Gut, 2004, 53: 1701–1709

    Article  Google Scholar 

  15. Marshman E, Ottewell P D, Potten C S, et al. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol, 2001, 195: 285–292

    Article  Google Scholar 

  16. Remmele W, Stegner H E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Der Pathologe, 1987, 8: 138–140

    Google Scholar 

  17. Magerla C, Ellinger J, Braunschweig T, et al. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum Pathol, 2010, 41: 181–189

    Article  Google Scholar 

  18. Adachi T, Schamel W W, Kim K M, et al. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J, 1996, 15: 1534–1541

    Google Scholar 

  19. Ladasky J J, Boyle S, Seth M, et al. Bap31 enhances the endoplasmic reticulum export and quality control of human class I MHC molecules. J Immunol, 2006, 177: 6172–6181

    Google Scholar 

  20. Manley H A, Lennon V A. Endoplasmic reticulum membrane-sorting protein of lymphocytes (BAP31) is highly expressed in neurons and discrete endocrine cells. J Histochem Cytochem, 2001, 49: 1235–1244

    Article  Google Scholar 

  21. Wang B, Nguyen M, Breckenridge D G, et al. Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochromec from mitochondria. J Biol Chem, 2003, 278: 14461–14468

    Article  Google Scholar 

  22. Nieto-Miguel T, Fonteriz R I, Vay L, et al. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res, 2007, 67: 10368–10378

    Article  Google Scholar 

  23. Mosser J, Sarde C O, Vicaire S, et al. A new human gene (DXS1357E) with ubiquitous expression, located in Xq28 adjacent to the adrenoleukodystrophy gene. Genomics, 1994, 22: 469–471

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Surgical Oncology Laboratory, Peking University People’s Hospital, Peking University, Beijing, 100044, China

    LingYi Dong, KeWei Jiang, YanBin Zhang, Hui Zhang, HongQing Zhuo, ZhiRong Cui, YingJiang Ye & Shan Wang

Authors
  1. LingYi Dong
    View author publications

    Search author on:PubMed Google Scholar

  2. KeWei Jiang
    View author publications

    Search author on:PubMed Google Scholar

  3. YanBin Zhang
    View author publications

    Search author on:PubMed Google Scholar

  4. Hui Zhang
    View author publications

    Search author on:PubMed Google Scholar

  5. HongQing Zhuo
    View author publications

    Search author on:PubMed Google Scholar

  6. ZhiRong Cui
    View author publications

    Search author on:PubMed Google Scholar

  7. YingJiang Ye
    View author publications

    Search author on:PubMed Google Scholar

  8. Shan Wang
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to YingJiang Ye or Shan Wang.

Additional information

These authors contributed equally to this work.

This article is published with open access at Springerlink.com

Rights and permissions

This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.

About this article

Cite this article

Dong, L., Jiang, K., Zhang, Y. et al. BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis. Chin. Sci. Bull. 56, 2444–2449 (2011). https://doi.org/10.1007/s11434-011-4610-0

Download citation

  • Received: 18 February 2011

  • Accepted: 04 May 2011

  • Published: 20 July 2011

  • Issue Date: August 2011

  • DOI: https://doi.org/10.1007/s11434-011-4610-0

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • BAP31
  • colorectal cancer
  • immunohistochemistry
  • tissue microarray
  • prognostic marker
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Discover content

  • Journals A-Z
  • Books A-Z

Publish with us

  • Journal finder
  • Publish your research
  • Language editing
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our brands

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Discover
  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support
  • Legal notice
  • Cancel contracts here

152.53.39.118

Not affiliated

Springer Nature

© 2025 Springer Nature